Suvretta Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $60.7M | Sell |
|
|||||
|
2025
Q2 | $82.8M | Buy |
|
|||||
|
2025
Q1 | $73.3M | Buy |
|
|||||
|
2024
Q4 | $48.4M | Hold |
|
|||||
|
2024
Q3 | $64M | Sell |
|
|||||
|
2024
Q2 | $84.7M | Buy |
|
|||||
|
2024
Q1 | $78.3M | Sell |
|
|||||
|
2023
Q4 | $102M | Buy |
|
|||||
|
2023
Q3 | $24.2M | Buy |
|
|||||
|
2023
Q2 | $25M | Sell |
|
|||||
|
2023
Q1 | $24.7M | Sell |
|
|||||
|
2022
Q4 | $37.9M | Buy |
|
|||||
|
2022
Q3 | $3.68M | Sell |
|
|||||
|
2022
Q2 | $20.8M | Sell |
|
|||||
|
2022
Q1 | $38.1M | Buy |
|
|||||
|
2021
Q4 | $40.8M | Buy |
|